News Pharmsynthez

Equities

LIFE

RU000A0JR514

End-of-day quote Moscow Micex - RTS Other stock markets 23:00:00 07/07/2022 BST			5-day change	1st Jan Change
4.505 ^RUB	+10.15%		-.--%	-.--%

2023	Public Joint-Stock Company "Pharmsynthez" Auditor Raises 'Going Concern' Doubt	CI
2023	Public Joint-Stock Company "Pharmsynthez" Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Public Joint-Stock Company "Pharmsynthez" Auditor Raises 'Going Concern' Doubt	18/05/23	CI
Public Joint-Stock Company "Pharmsynthez" Reports Earnings Results for the Full Year Ended December 31, 2022	18/05/23	CI
Public Joint-Stock Company "Pharmsynthez" announced that it expects to receive funding from Central Bank of the Russian Federation	07/11/22	CI
Public Joint-Stock Company "Pharmsynthez" Auditor Raises 'Going Concern' Doubt	27/04/22	CI
Public Joint-Stock Company "Pharmsynthez" Reports Earnings Results for the Half Year Ended June 30, 2021	11/11/21	CI
Xenetic Biosciences, Inc. Enters into Amendment Number One to Master Services Agreement with PJSC Pharmsynthez	15/10/21	CI
Market Chatter: South Korean Regulator Rejects Thelma Therapeutics's Phase Three Trial for COVID-19 Cure	14/04/21	MT
Public Joint-Stock Company Pharmsynthez Reports Earnings Results for the Full Year Ended December 31, 2018	01/03/21	CI
PJSC Pharmsynthez Starts the Registration Phase of Epolong	15/02/21	CI
HiFiBiO Therapeutics Inks Partnership with Pharmsynthez and IBCh for the Clinical Development and Commercialization of its SARS-CoV-2 Neutralizing Antibody in Russia	23/11/20	CI
Public Joint-Stock Company "Pharmsynthez" acquired remaining unknown minority stake in VAKTSINY.	18/11/20	CI
Xenetic Biosciences, Inc. and PJSC Pharmsynthez Enters into Master Service Agreement to Advance the Development of Xcart Technology	16/06/20	CI
Public Joint-Stock Company "Pharmsynthez" Auditor Raises 'Going Concern' Doubt	26/07/18	CI
Pharmsynthez Appoints Members of Audit Commission	06/07/18	CI
Rusnano To Sell Its Stake In Pharmsynthez	25/10/17	CI
Public Joint-Stock Company Pharmsynthez announced that it has received RUB 3.80 billion in funding	27/10/16	CI
Pharmsynthez Reports Earnings Results for the Six Months of 2016	29/08/16	CI
OJSC Pharmsynthez Reports Earnings Results for the Six Months Ended June 30, 2016	15/08/16	CI
PJSC Pharmsynthez Announces Earnings Results for the First Quarter of 2016	16/05/16	CI
Xenetic Biosciences, Inc. announced that it has received $3.5 million in funding from Public Joint-Stock Company Pharmsynthez	30/03/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Pharmsynthez

Equities

LIFE

RU000A0JR514

Summary

Filters